Product Images Cefoxitin And Dextrose

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Cefoxitin And Dextrose NDC 0264-3125 by B. Braun Medical Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Cefoxitin sodium - cefoxitin for injection and dextrose injection in 1

Cefoxitin sodium - cefoxitin for injection and dextrose injection in  1

3125-11 50mL 2g Container Label - cefoxitin for injection and dextrose injection in 10

3125-11 50mL 2g Container Label - cefoxitin for injection and dextrose injection in  10

This is a description of Cefoxitin for Injection and Dextrose Injection contained in a 50mL Duplex container used for intravenous administration. It contains cefoxitin sodium equivalent to 2g, and is recommended to be mixed with a measured volume of the diluent before administration. The instructions for mixing and administration are described in detail in the text. The container is made without natural rubber and is meant for single-dose use. The product is by B Braun Medical.*

Drug Chamber Label - cefoxitin for injection and dextrose injection in 11

Drug Chamber Label - cefoxitin for injection and dextrose injection in  11

This is a label or instruction text for a drug chamber. It advises the user to discard the unit if the foil strip is damaged, and to only peel the foil strip when ready for use. The user is also advised to visually inspect the drug prior to reconstitution, and to refer to the package insert for complete directions for reconstitution and administration.*

Dextrous hydrous - cefoxitin for injection and dextrose injection in 2

Dextrous hydrous - cefoxitin for injection and dextrose injection in  2

Diagram 1 - cefoxitin for injection and dextrose injection in 3

Diagram 1 - cefoxitin for injection and dextrose injection in  3

Diagram 2 - cefoxitin for injection and dextrose injection in 4

Diagram 2 - cefoxitin for injection and dextrose injection in  4

Diagram 3 - cefoxitin for injection and dextrose injection in 5

Diagram 3 - cefoxitin for injection and dextrose injection in  5

Diagram 4 - cefoxitin for injection and dextrose injection in 6

Diagram 4 - cefoxitin for injection and dextrose injection in  6

Diagram 5 - cefoxitin for injection and dextrose injection in 7

Diagram 5 - cefoxitin for injection and dextrose injection in  7

3123-11 50 mL 1g Container Label - cefoxitin for injection and dextrose injection in 8

3123-11 50 mL 1g Container Label - cefoxitin for injection and dextrose injection in  8

This is a description of a medication called Cefoxitin for Injection and Dextrose Injection contained within a 50mL DUPLEX® container for intravenous (IV) use. The container is single-dose and sterile/nonpyrogenic, with cefoxitin content equivalent to 1g. It includes instructions for activation by squeezing the chamber below the suction ports. The activated container contains Cefoxitin Sodium USP and Dextrose USP in specified concentrations. The solution is to be stored at room temperature and used within 7-8 hours of preparation. It is free from natural rubber latex, PVC or DEHP. Rx only.*

Drug Chamber Label - cefoxitin for injection and dextrose injection in 9

Drug Chamber Label - cefoxitin for injection and dextrose injection in  9

This is a label instruction for a drug chamber. It asks the user to discard the unit if the foil strip is damaged and to visually inspect the drug prior to using it. The label also suggests that the user must see the package insert for complete directions for reconstitution and administration.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.